ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q3Scopus Q2SCImago #7,810Hybrid

Molecular Biotechnology

Acronym:mobi
•
Abbreviation (ISO):MOL. BIOTECHNOL
•
Identifier (ISSN):1073-6085(Print)/1559-0305(Online)
•
Publisher:Springer US
Clarivate IF (2026)
3.2↑ +0.7
Journal Impact Factor
IF Trend↓
WoS Quartile
Q3
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2020–2026)

Clarivate IF trend for Molecular Biotechnology

WoS Q3
12452.0220202.6920212.8620222.620232.420242.520253.22026
Annual Impact Factor Metric
Current (2026):3.2
Scopus SJR & RankScopus Q2
0.731
#7,810

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
98

98 papers with at least that number of citations each

WoS: SCIE / JCRQ3
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
138articles/year
9.24% Gold OA•84.85% Original Research

Aims & Scope

Molecular Biotechnology publishes original research papers on the application of molecular biology to both basic and applied research in the field of biotechnology. Particular areas of interest include the following: stability and expression of cloned gene products, cell transformation, gene cloning systems and the production of recombinant proteins, protein purification and analysis, transgenic species, developmental biology, mutation analysis, the applications of DNA fingerprinting, RNA interference, and PCR technology, microarray technology, proteomics, mass spectrometry, bioinformatics, plant molecular biology, microbial genetics, gene probes and the diagnosis of disease, pharmaceutical and health care products, therapeutic agents, vaccines, gene targeting, gene therapy, stem cell technology and tissue engineering, antisense technology, protein engineering and enzyme technology, monoclonal antibodies, glycobiology and glycomics, and agricultural biotechnology.

Topics Covered (Recognized by AI)
Biology99.2%Genetics85.5%Chemistry85.2%Biochemistry83.5%Gene73.8%Medicine48.4%Molecular biology37.6%Physics35.3%Organic chemistry34.2%Computational biology34.1%Nuclear magnetic resonance26.4%Internal medicine26.4%DNA24%Enzyme23.4%Immunology22.5%Recombinant DNA21%Gene expression20.3%

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

BIOCHEMISTRY & MOLECULAR BIOLOGY

Q3
Rank185/328
IndexSCIE
JCRSCIE2026

BIOTECHNOLOGY & APPLIED MICROBIOLOGY

Q3
Rank95/180
IndexSCIE
JCISCIE2026

BIOCHEMISTRY & MOLECULAR BIOLOGY

Q3
Rank231/328
IndexSCIE
JCISCIE2026

BIOTECHNOLOGY & APPLIED MICROBIOLOGY

Q3
Rank118/180
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF3.2
Articles / Year65
Total Citations18
2025
IF2.5
Articles / Year192
Total Citations458
2024
IF2.4
Articles / Year330
Total Citations1,890
2023
IF2.6
Articles / Year360
Total Citations3,783
2022
IF2.86
Articles / Year204
Total Citations2,578

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #7,810Scopus Q2SCImago Profile
Scopus Coverage:1994-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyChemical EngineeringImmunology and Microbiology
Scopus Citation Rank (SJR)Q2
0.731

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
4.06

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,009 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations2,274
3-Year Documents599
Citable Documents597

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate43.0%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Applied Microbiology and BiotechnologyQ2
BiochemistryQ2
BioengineeringQ2
BiotechnologyQ2
Molecular BiologyQ3
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Biology
Minor Category (Specific Field):
4区BIOCHEMISTRY & MOLECULAR BIOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Molecular Biotechnology (acronym: mobi, abbr: MOL. BIOTECHNOL, ISSN: 1073-6085) is a peer-reviewed international scholarly journal in the field of Medicine, published by Springer US in United States since 1994. The periodical holds a Journal Impact Factor (JIF) of 3.20, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.731 (Q2), an H-index of 98.

The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 138 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,009 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Springer US
Publication Language
English
Frequency
Monthly
Founding Year
1994
Indexing & Databases
SCIEScopusPubMed
Editorial Address
HUMANA PRESS INC, 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, USA, NJ, 07512

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: ded0f047-5e0d-4275-9d16-38fc837516e9
Database Updated: 2026-10-01